Cytek Biosciences, Inc. (CTKB)
USD 3.65
(-2.02%)
USD 3.65
(-2.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -12.14 Million USD | -571.58% |
| 2022 | 2.57 Million USD | -41.68% |
| 2021 | 4.41 Million USD | -77.24% |
| 2020 | 19.41 Million USD | 215.36% |
| 2019 | -16.82 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 941 Thousand USD | 109.02% |
| 2024 Q2 | -10.43 Million USD | -69.14% |
| 2024 Q1 | -6.16 Million USD | -212.1% |
| 2023 FY | -12.14 Million USD | -571.58% |
| 2023 Q1 | -6.8 Million USD | -292.89% |
| 2023 Q2 | -4.38 Million USD | 35.54% |
| 2023 Q3 | -6.45 Million USD | -47.13% |
| 2023 Q4 | 5.5 Million USD | 185.24% |
| 2022 FY | 2.57 Million USD | -41.68% |
| 2022 Q4 | 3.52 Million USD | 111.82% |
| 2022 Q3 | 1.66 Million USD | 378.6% |
| 2022 Q2 | -598 Thousand USD | 72.29% |
| 2022 Q1 | -2.15 Million USD | -1059.11% |
| 2021 Q1 | 102 Thousand USD | -98.18% |
| 2021 Q4 | 225 Thousand USD | -85.89% |
| 2021 Q3 | 1.59 Million USD | -40.26% |
| 2021 Q2 | 2.67 Million USD | 2517.65% |
| 2021 FY | 4.41 Million USD | -77.24% |
| 2020 FY | 19.41 Million USD | 215.36% |
| 2020 Q3 | 6.54 Million USD | -19.37% |
| 2020 Q4 | 5.59 Million USD | -14.39% |
| 2020 Q2 | 8.11 Million USD | 1066.75% |
| 2020 Q1 | -839 Thousand USD | 0.0% |
| 2019 FY | -16.82 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cerus Corporation | -37.48 Million USD | 67.596% |
| OrthoPediatrics Corp. | -20.97 Million USD | 42.081% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -2.433% |
| TELA Bio, Inc. | -46.66 Million USD | 73.967% |
| Spectral AI, Inc. | -20.85 Million USD | 41.747% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 80.012% |
| CVRx, Inc. | -41.19 Million USD | 70.514% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1997.544% |
| Acutus Medical, Inc. | -81.66 Million USD | 85.124% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -10.887% |
| Talis Biomedical Corporation | -62 Million USD | 80.409% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 80.285% |
| Bioventus Inc. | -156.23 Million USD | 92.224% |
| BrainsWay Ltd. | -4.19 Million USD | -189.445% |
| Envoy Medical, Inc. | -29.9 Million USD | 59.382% |
| electroCore, Inc. | -18.83 Million USD | 35.5% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -37.266% |
| IceCure Medical Ltd | -14.65 Million USD | 17.09% |
| Inogen, Inc. | -102.44 Million USD | 88.142% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 76.934% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 11.62% |
| MaxCyte, Inc. | -37.92 Million USD | 67.967% |
| Nexalin Technology, Inc. | -4.64 Million USD | -161.32% |
| Orthofix Medical Inc. | -151.39 Million USD | 91.976% |
| PAVmed Inc | -64.17 Million USD | 81.071% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 76.846% |
| RxSight, Inc. | -48.6 Million USD | 75.008% |
| Sight Sciences, Inc. | -55.54 Million USD | 78.13% |
| SI-BONE, Inc. | -43.33 Million USD | 71.968% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 75.472% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 10.565% |
| Venus Concept Inc. | -37.25 Million USD | 67.388% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 79.423% |
| LivaNova PLC | 17.54 Million USD | 169.235% |
| 908 Devices Inc. | -36.39 Million USD | 66.625% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 93.491% |
| Nemaura Medical Inc. | -14.14 Million USD | 14.11% |
| NeuroPace, Inc. | -32.95 Million USD | 63.139% |
| LENSAR, Inc. | -14.38 Million USD | 15.539% |
| Apyx Medical Corporation | -18.71 Million USD | 35.083% |
| Cutera, Inc. | -162.83 Million USD | 92.54% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -12.17% |
| BioSig Technologies, Inc. | -29.04 Million USD | 58.169% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 85.305% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 45.004% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 117.933% |
| Axonics, Inc. | -6.08 Million USD | -99.54% |
| Outset Medical, Inc. | -172.79 Million USD | 92.97% |
| IRIDEX Corporation | -9.57 Million USD | -26.938% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 88.528% |
| IRadimed Corporation | 17.19 Million USD | 170.658% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -47.356% |
| INVO Bioscience, Inc. | -8.03 Million USD | -51.196% |
| Telesis Bio, Inc. | -47.72 Million USD | 74.545% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 218.598% |
| Varex Imaging Corporation | -47.7 Million USD | 74.532% |
| Quipt Home Medical Corp. | -2.78 Million USD | -336.351% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -7.638% |
| Pulmonx Corporation | -60.84 Million USD | 80.034% |
| Dynatronics Corporation | -2.69 Million USD | -350.306% |
| Modular Medical, Inc. | -17.47 Million USD | 30.464% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -6.683% |
| Semler Scientific, Inc. | 20.58 Million USD | 159.02% |
| InMode Ltd. | 197.91 Million USD | 106.138% |
| Bruker Corporation | 427.2 Million USD | 102.844% |
| Cytosorbents Corporation | -28.5 Million USD | 57.386% |
| DexCom, Inc. | 541.5 Million USD | 102.243% |
| Align Technology, Inc. | 445.05 Million USD | 102.73% |
| Viveve Medical, Inc. | -22.02 Million USD | 44.85% |
| ZimVie Inc. | -393.28 Million USD | 96.911% |
| Movano Inc. | -29.28 Million USD | 58.515% |
| Nexalin Technology, Inc. | -4.64 Million USD | -161.32% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1997.544% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 94.543% |
| Profound Medical Corp. | -28.56 Million USD | 57.478% |
| Insulet Corporation | 206.3 Million USD | 105.889% |
| enVVeno Medical Corporation | -23.51 Million USD | 48.342% |
| Surmodics, Inc. | -11.54 Million USD | -5.25% |
| iCAD, Inc. | -4.84 Million USD | -150.629% |
| Nuwellis, Inc. | -20.2 Million USD | 39.888% |
| Biotricity, Inc. | -14.09 Million USD | 13.809% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 90.156% |
| Aethlon Medical, Inc. | -12.2 Million USD | 0.493% |
| InspireMD, Inc. | -19.91 Million USD | 39.004% |
| PAVmed Inc. | -64.17 Million USD | 81.071% |
| BIOLASE, Inc. | -20.63 Million USD | 41.121% |
| Beyond Air, Inc. | -60.24 Million USD | 79.835% |
| FONAR Corporation | 10.56 Million USD | 214.957% |
| AxoGen, Inc. | -21.71 Million USD | 44.06% |
| Vivani Medical, Inc. | -25.65 Million USD | 52.643% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 142.602% |
| Inari Medical, Inc. | -1.63 Million USD | -642.543% |
| UFP Technologies, Inc. | 44.92 Million USD | 127.041% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -136.696% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -83.915% |
| Tenon Medical, Inc. | -15.58 Million USD | 22.033% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 21.25% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 65.618% |
| AdaptHealth Corp. | -678.89 Million USD | 98.211% |
| Sintx Technologies, Inc. | -8.25 Million USD | -47.088% |
| NanoVibronix, Inc. | -3.71 Million USD | -227.351% |
| Quanterix Corporation | -32.33 Million USD | 62.43% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -7.638% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2604.742% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.04% |
| TransMedics Group, Inc. | -25.02 Million USD | 51.462% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 45.114% |
| NeuroMetrix, Inc. | -6.52 Million USD | -86.048% |
| Hyperfine, Inc. | -44.23 Million USD | 72.539% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 84.525% |
| Biomerica, Inc. | -5.97 Million USD | -103.212% |
| Bone Biologics Corporation | -8.94 Million USD | -35.751% |
| AVITA Medical, Inc. | -39.16 Million USD | 68.985% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -22.043% |
| Silk Road Medical, Inc | -55.74 Million USD | 78.207% |